Distinguished Speakers


Dr. Brian Mark, University of Manitoba
Towards an Enzyme Replacement Therapy for Tay-Sachs and Sandhoff Disease
March 19

Dr. Sheetal Raithatha, Symvivo Corp
bacTRL-Spike™: A Novel Bacterial-based Gene Delivery Platform for Targeted Cancer Therapy
March 10

Dr. Matt Schellenberg, Mayo Clinic
New Protein Production Tools and New Topoisomerases
February 26

Dr. Craig Markin, Stanford University
Revealing Enzyme Functional Architecture Via High-throughput Microfluidic Enzyme Kinetics
February 5

Dr. Albert Berghuis, McGill University
Resistance is Futile … Unfortunately No. A Structural Perspective on Antibiotic Resistance
January 29

Dr. Trevor Moraes, University of Toronto
The surface lipoproteins of Gram-negative bacteria: protectors and foragers in harsh environments
January 15



Dr. Nehalkumar Thakor, University of Lethbridge
Regulation of Protein Synthesis: From Mechanism to Cancer Cell Survival
December 9

Dr. John Rubinstein, University of Toronto
Cryo-EM of Macromolecular Machines at Energized Membranes
November 20

Dr. Pablo Artigas, Texas Tech University Health Sciences Center
Na+/K+-Pump Mechanisms and their Relevance for Physio and Pathophysiological States
February 26

Dr. Olivier Peyruchaud, French Institute of Health and Medical Research
The Dialogue Between Platelets and Cancer Cells in Promoting Metastasis
February 19



Dr. Hans Vogel, University of Calgary
Calcium-binding to L-plastin regulates actin-bundling: target for new antimetastasis drugs
December 9

Dr. Martin Tollinger, University of Innsbruck
NMR Spectroscopy of Protein Allergens
August 30

Dr. Shirin Bonni, University of Calgary
Regulation of Epithelial Cell Plasticity
August 30

Dr. Erique Lukong, University of Saskatchewan
Breast Tumor Kinase: A Potential Therapeutic Target in Breast Cancer?
August 2

Dr. Mirek Cygler, University of Saskatchewan
Increased calcium sensitivity is the basis of hypertrophic cardiomyopathy for M-class cardiac actin variants
July 12

Dr. John Dawson, University of Guelph
Increased calcium sensitivity is the basis of hypertrophic cardiomyopathy for M-class cardiac actin variants
July 11

Dr. Natalie Strydnadka, FRS, University of British Columbia
Dr. Justin Fedor, Cambridge University
Dr. Ray Turner, University of Calgary
Presenting at our Career Celebration for Professor Joel Weiner
May 9

Dr. Russell Bishop, McMaster University
Presenting the multifunctional enzymology of PagP
May 9

Dr. Tatiana Kutaladze,University of Colorado
Molecular mechanisms of epigenetic regulation
April 3

Dr. Henkjan Verkade,University of Groningen, The Netherlands
Understanding, preventing and treating rare liver diseases
March 19

Dr. Sean McKenna,University of Manitoba
Recognition of Quadruplex RNA Structures by Helicases and Functional Consequences
January 16



Dmitry Semchonok,The Hebrew University of Jerusalem
Structural tools for life research
October 5

Dr. Mohan Babu,University of Regina
Description: Rewiring of Mitochondrial Network Organization during Neuronal Reprogramming
June 19

Dr. Gary S. Shaw, University of Western Ontario
The Structural Biology of Proteins In Early-Onset Parkinson's Disease; From Inhibition to Activation
June 15

Dr. Frank Sönnichsen, Christian-Albrechts-Universität zu Kiel, Germany
Protein Engineering without NCE
June 14

Dr. Heather Dettman, Natural Resources Canada,
NMR Spectroscopy and Petroleum
June 14

Dr. Joe O'Neil, University of Manitoba
Solubility Problems with Disordered Proteins
June 14

Dr. Jim Baleja, Tufts University
Epidermal Metabolomics
June 14

Patricia Campbell Ph.D., Partner at Jones Day
The Role of Patents in Biotechnology
June 14

Dr. Krishna Rajarathnam, University of Texas Medical Branch Galveston
Chemokine Monomers and Dimers: 25 Years Later.
June 14

Dr. Matt Crump, University of Bristol, UK
'Always pick a system' - Brian D. Sykes, Nucleus Meeting, 1998.
June 14

Dr. JianJun Wang, Wayne State University
Kill or no-Kill, A Choice for a New Cancer Therapy
June 14

Dr. Campbell McInnes, University of South Carolina
Inhibitors of B-Raf Kinase Block Dimerization and Overcome Paradoxical MEK/ERK Activation
June 14

Dr. Xu Wang, Arizona State University
NMR Studies of Glycosaminoglycan Binding Proteins
June 14

Dr. Tharin Blumenschein, University of East Anglia, UK
Intrinsically Disordered Proteins
June 14

Dr. Jan Rainey, Dalhousie University
Applying Fluorotryptophan Probes to Characterize Spider Silk and Membrane Proteins.
June 14

Dr. David Sykes, Massachusetts General Hospital
The Humble Neutrophil: What Are They Good For Anyway?
June 14

Dr. Sam Sia, Columbia University
Miniaturization for Next-generation Diagnostics and Therapeutics.
June 14

Dr. Lewis Kay, University of Toronto
It All Started Here: Spins, Proteins, and Magnets
June 14

Dr. Malcolm Irving, King's College London, UK and Francis Crick Institute, London, UK
Regulation of Contraction in Skeletal Muscle and in the Heart
June 13

Dr. Wayne Chen, University of Calgary
Ryanodine Receptor Store Ca2+ regulation: from Structure to Cardiac and Neurological Disorders
May 24

Dr. Grant Kemp, Stockholm University
Two's company: Cooperativity in co-translational protein folding
April 6

Dr. Nehalkumar Thakor, University of Lethbridge
Eukaryotic initiation factor 5B (eIF5B) promotes evasion of apoptosis in glioblastoma cells
March 28



Dr. John Pascal, Université de Montréal
Structural biology of poly(ADP-ribose) polymerase enzymes and the cellular response to DNA damage
November 28

Dr. Eigenio Hardy, Havana University
On the Development of the Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b
October 5

Dr. Timothy Durrett, Kansas State University
From Burning Bushes to Chocolate Vines: Using Sequence Diversity to Explore MBOAT Substrate Specificity and Increase Production of Low Viscosity Oil
September 28

Dr. Voula Kanelis, University of Toronto, Mississauga
The effect of regulatory interactions and disease mutations on the NBDs of SUR proteins, the regulatory subunits in KATP channels
September 8

Dr. Randall Cohrs, University of Colorado, Denver
Varicella zoster virus: a 31 year journey involving autopsies and astronauts
August 29

Dr. Stephen Young, University of California, Los Angeles
Discovery, design and development of human amylase inhibitors: from nM to pM
August 25

Dr. Miroslaw Cygler, University of Saskatchewan
Structure, function and dynamics of the mitochondrial Fe/S cluster synthesis complex
August 11

Dr. Mihoko Kai, Johns Hopkins Medical School
When RNA meets DNA repair
August 3

Dr. Mo Motamedi, Harvard Medical School
Quiescent-Induced Transcriptional Silencing (QuieTS) by RNAi and heterochromatin
July 5

Dr. Charles Sanders, Vanderbilt University
The Scarlet Letter: The Role of Membrane Protein Misfolding in Charcot-Marie-Tooth Disease
June 23

Dr. Randy Read, University of Cambridge
An unexpected crystallographic insight into renin secretion
June 15

Dr. Natalie Strynadka, UBC
Hybrid structural methods to probe transport assemblies on the bacterial membrane
June 15

Dr. Amir Khan, Trinity College, Ireland
Poxvirus antagonism of host innate immunity
June 15

Dr. Stephen Withers, University of British Columbia
Discovery, design and development of human amylase inhibitors: from nM to pM
June 14

Dr. Reinhart Reithmeier, University of Toronto
Folding and Misfolding of membrane proteins: the red cell Band 3 anion exchanger in human health and disease
April 27

Dr. Wilfred F. van Gunsteren, Swiss Federal Institute of Technology
Challenges in Molecular Dynamics Simulations of Bio-molecules: On Comparing Simulated with Experimental Data
March 31

Dr. Brian Mark, University of Manitoba
Corrupting the ubiquitin system: a viral strategy to evade host immunity
March 17